{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:05:46Z","timestamp":1780067146230,"version":"3.54.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1801,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1093\/annonc\/mdu518","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T04:49:58Z","timestamp":1415854198000},"page":"374-377","source":"Crossref","is-referenced-by-count":41,"title":["Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy"],"prefix":"10.1016","volume":"26","author":[{"given":"A.D.","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Karamitopoulou-Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Fey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.E.","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdu518_bb0010","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2003.01.094","article-title":"Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review","volume":"21","author":"Vergouwe","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mdu518_bb0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0022-5347(05)67528-3","article-title":"Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection","volume":"163","author":"Hermans","year":"2000","journal-title":"J Urol"},{"issue":"8","key":"10.1093\/annonc\/mdu518_bb0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2003.07.169","article-title":"Risk factors for relapse in clinical stage I","volume":"21","author":"Albers","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdu518_bb0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2011.05.038","article-title":"EAU Guidelines on testicular cancer: 2011 update","volume":"60","author":"Albers","year":"2011","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdu518_bb0030","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Testicular Cancer Version 1.2012 http:\/\/www.nccn.org (10 July 2014, date last accessed)"},{"issue":"6","key":"10.1093\/annonc\/mdu518_bb0035","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/annonc\/mdp473","article-title":"Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy","volume":"21","author":"Kollmannsberger","year":"2010","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdu518_bb0040","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.1996.14.4.1106","article-title":"Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report","volume":"14","author":"Cullen","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdu518_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1996.14.2.441","article-title":"Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial","volume":"14","author":"Pont","year":"1996","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdu518_bb0050","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-5347(01)61615-X","article-title":"Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors","volume":"161","author":"Bohlen","year":"1999","journal-title":"J Urol"},{"issue":"2","key":"10.1093\/annonc\/mdu518_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2004.03.022","article-title":"Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and\/or vascular invasion","volume":"46","author":"Chevreau","year":"2004","journal-title":"Eur Urol"},{"issue":"3","key":"10.1093\/annonc\/mdu518_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2003.10.023","article-title":"Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy","volume":"63","author":"Oliver","year":"2004","journal-title":"Urology"},{"issue":"13","key":"10.1093\/annonc\/mdu518_bb0065","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1200\/JCO.2008.18.8953","article-title":"Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program","volume":"27","author":"Tandstad","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdu518_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.urolonc.2009.01.017","article-title":"Report of the long-term efficacy of two cycles of adjuvant bleomycin\/etoposide\/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group","volume":"29","author":"Bamias","year":"2011","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdu518_bb0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2011.05.055","article-title":"Sequelae of treatment in long-term survivors of testis cancer","volume":"60","author":"Abouassaly","year":"2011","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdu518_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu375","article-title":"One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group","author":"Tandstad","year":"2014","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1093\/annonc\/mdu518_bb0085","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1200\/JCO.2007.12.0899","volume":"26","author":"Albers","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdu518_bb0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1464-410X.2006.06188.x","article-title":"Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy","volume":"98","author":"Gilbert","year":"2006","journal-title":"BJU Int"},{"issue":"1","key":"10.1093\/annonc\/mdu518_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.juro.2007.08.172","article-title":"Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis","volume":"179","author":"Westermann","year":"2008","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdu518_bb0100","series-title":"Pathology & Genetics: Tumours of the Urinary System and Male Genital Organs","first-page":"250","article-title":"WHO Histological Classification of Testis Tumours","volume":"218","author":"Eble","year":"2004"},{"key":"10.1093\/annonc\/mdu518_bb0105","first-page":"249","article-title":"TNM Classification of Malignant Tumors. UICC. International Union Against Cancer","author":"Sobin","year":"2009"},{"key":"10.1093\/annonc\/mdu518_bb0110","unstructured":"U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf (10 July 2014, date last accessed)"},{"issue":"8","key":"10.1093\/annonc\/mdu518_bb0115","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1464-410X.2012.11056.x","article-title":"Bilateral testicular germ cell tumours: a systematic review","volume":"110","author":"Zequi","year":"2012","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mdu518_bb0120","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1200\/JCO.2013.50.3409","article-title":"Solid tumors after chemotherapy of surgery for testicular nonseminoma: a population-based study","volume":"31","author":"Fung","year":"2013","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1093\/annonc\/mdu518_bb0125","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/cncr.26038","article-title":"Secondary malignancies among nonseminomatous germ cell tumor cancer survivors","volume":"117","author":"Chamie","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu518_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00345-009-0456-3","article-title":"High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy","volume":"27","author":"Westermann","year":"2009","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mdu518_bb0135","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu518_bb0140","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu518_bb0145","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djp413","article-title":"Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors","volume":"101","author":"Bryd\u00f8y","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1093\/annonc\/mdu518_bb0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","article-title":"A comprehensive systematic review of testicular germ cell tumor surveillance","volume":"64","author":"Groll","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"issue":"28","key":"10.1093\/annonc\/mdu518_bb0155","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1200\/JCO.2005.21.956","article-title":"Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy","volume":"23","author":"Ronnen","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419313729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419313729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/2\/374\/19480294\/mdu518.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:45:37Z","timestamp":1624520737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419313729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0923753419313729"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu518","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}